Craneware (LON:CRW) Hits New 12-Month High at $2,278.00

Craneware plc (LON:CRW)’s stock price hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as GBX 2,278 ($28.14) and last traded at GBX 2,275 ($28.10), with a volume of 50163 shares traded. The stock had previously closed at GBX 2,230 ($27.54).

Wall Street Analyst Weigh In

Separately, Berenberg Bank boosted their price objective on Craneware from GBX 2,300 ($28.41) to GBX 2,600 ($32.11) and gave the stock a “buy” rating in a report on Monday, March 4th.

Craneware Trading Up 1.9 %

The company has a market cap of £803.51 million, a P/E ratio of 10,585.71 and a beta of 0.14. The business has a fifty day moving average price of GBX 2,174.80 and a 200-day moving average price of GBX 1,899.19. The company has a quick ratio of 1.00, a current ratio of 0.78 and a debt-to-equity ratio of 19.15.

Craneware Cuts Dividend

The company also recently disclosed a dividend, which was paid on Monday, April 15th. Stockholders of record on Thursday, March 21st were issued a dividend of GBX 13 ($0.16) per share. This represents a dividend yield of 0.62%. The ex-dividend date of this dividend was Thursday, March 21st. Craneware’s dividend payout ratio is presently 13,809.52%.

Craneware Company Profile

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Trisus pricing transparency software; Trisus Pricing Analyzer, a solution that simplifies and automates the price modeling process; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, a solution that offers medical necessity for the United States payors; Trisus Claims Informatics, a retrospective charge capture analytical application that identifies areas of risk for its team to investigate; Trisus Supply, a solution that improves supplies reimbursement; and InSight Audit, an audit management solution for government and commercial payors.